NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to ...
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $111.57, a high estimate of $134.00, and a low estimate of $92.00. This current ...
Orbis Flying Eye Hospital (FEH), the world's only fully accredited ophthalmic teaching hospital aboard an MD-10 aircraft, championed by Global eye care nonprofit organisation Orbis International, has ...
Global eye care nonprofit Orbis International announces the start of a training project today in Ghana on board the Orbis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback